Daiichi Sankyo Co., A Japanese pharma company, will buy the 38% stake of the Singh family in Ranbaxy and possibly a further 20% ( on account of the open-offer they will have to make).
This will give Daiichi access to the fast-growing generic drung market and capability.
The jury is still out on whether it meant business sense for MMS and SMS.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment